Simulations Plus (NASDAQ:SLP) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Simulations Plus (NASDAQ:SLP) from a hold rating to a buy rating in a research note issued to investors on Saturday.

Other equities analysts also recently issued research reports about the company. TD Cowen lowered their price target on Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 10th. Zacks Research downgraded Simulations Plus from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 2nd. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $24.40.

Simulations Plus Stock Performance

NASDAQ:SLP opened at $13.34 on Friday. The stock’s 50-day simple moving average is $13.23 and its 200 day simple moving average is $15.77. The company has a market cap of $269.47 million, a P/E ratio of -4.26 and a beta of 1.28. Simulations Plus has a 52-week low of $11.09 and a 52-week high of $34.01.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Thursday, April 9th. The technology company reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.08. The business had revenue of $24.29 million for the quarter, compared to the consensus estimate of $21.66 million. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%. As a group, equities analysts predict that Simulations Plus will post 0.85 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Simulations Plus

Several institutional investors and hedge funds have recently made changes to their positions in the company. Quantinno Capital Management LP grew its position in shares of Simulations Plus by 439.1% in the first quarter. Quantinno Capital Management LP now owns 112,259 shares of the technology company’s stock valued at $1,327,000 after purchasing an additional 91,434 shares during the last quarter. First Light Asset Management LLC grew its position in shares of Simulations Plus by 33.7% in the first quarter. First Light Asset Management LLC now owns 2,632,823 shares of the technology company’s stock valued at $31,120,000 after purchasing an additional 663,906 shares during the last quarter. Rice Hall James & Associates LLC grew its position in shares of Simulations Plus by 44.8% in the first quarter. Rice Hall James & Associates LLC now owns 101,598 shares of the technology company’s stock valued at $1,201,000 after purchasing an additional 31,413 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of Simulations Plus by 807.5% in the first quarter. Renaissance Technologies LLC now owns 181,500 shares of the technology company’s stock valued at $2,145,000 after purchasing an additional 161,500 shares during the last quarter. Finally, Public Employees Retirement System of Ohio grew its position in shares of Simulations Plus by 44.6% in the first quarter. Public Employees Retirement System of Ohio now owns 47,435 shares of the technology company’s stock valued at $561,000 after purchasing an additional 14,636 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.